OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.
Charlie F Rowlands, Sophie Allen, Judith Balmañà, et al.
Annals of Oncology (2024) Vol. 35, Iss. 10, pp. 892-901
Open Access | Times Cited: 5
Charlie F Rowlands, Sophie Allen, Judith Balmañà, et al.
Annals of Oncology (2024) Vol. 35, Iss. 10, pp. 892-901
Open Access | Times Cited: 5
Showing 5 citing articles:
Impact of NICE Guideline NG241 ‘Ovarian Cancer: identifying and managing familial and genetic risk’ on a regional NHS family history and clinical genetics service
A M Roe, Andrea Forman, Fiona Lalloo, et al.
Journal of Medical Genetics (2025), pp. jmg-110481
Open Access
A M Roe, Andrea Forman, Fiona Lalloo, et al.
Journal of Medical Genetics (2025), pp. jmg-110481
Open Access
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores
Peeter Padrik, Neeme Tõnisson, Tone Hovda, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1056-1056
Open Access
Peeter Padrik, Neeme Tõnisson, Tone Hovda, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1056-1056
Open Access
Genetic insights into BRCA1/2 associated breast cancer in Türkiye: focus on early-onset and aggressive subtypes
Betül Çelik, Seda Kılıç, Özge Şükrüoğlu Erdoğan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Betül Çelik, Seda Kılıç, Özge Şükrüoğlu Erdoğan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer
Holly J. Pederson, Steven A. Narod
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Holly J. Pederson, Steven A. Narod
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol
Stefano Ferretti, Priscilla Sassoli de Bianchi, Debora Canuti, et al.
Methods and Protocols (2024) Vol. 7, Iss. 4, pp. 63-63
Open Access | Times Cited: 1
Stefano Ferretti, Priscilla Sassoli de Bianchi, Debora Canuti, et al.
Methods and Protocols (2024) Vol. 7, Iss. 4, pp. 63-63
Open Access | Times Cited: 1
Secondary Risk-Reducing Strategies for Contralateral Breast Cancer in BRCA1/2 Variant Carriers: A Systematic Review and Meta-analysis
Jing Yu, Shan Jiang, Taoran Liu, et al.
Advances in Therapy (2024)
Closed Access
Jing Yu, Shan Jiang, Taoran Liu, et al.
Advances in Therapy (2024)
Closed Access
